M&A: Page 2
-
Mario Tama / Staff via Getty Images
Top 10 medtech deals of 2024
Multibillion-dollar buyouts returned last year, led by Johnson & Johnson’s $13.1 billion acquisition of Shockwave Medical.
By Nick Paul Taylor • Jan. 2, 2025 -
Justin Sullivan via Getty Images
Labcorp closes takeover of Ballad Health outreach laboratory services
Labcorp continued its streak of hospital lab purchases with a deal that will expand its testing capabilities to communities in Tennessee, Virginia, North Carolina and Kentucky.
By Nick Paul Taylor • Dec. 12, 2024 -
skynesher via Getty Images
Patterson, a dental products distributor, agrees to $4.1B sale to healthcare investor
Last week, Patterson Companies announced it would seek strategic alternatives after the company’s profit decreased by one-third in its fiscal second quarter.
By Elise Reuter • Dec. 11, 2024 -
Chip Somodevilla via Getty Images
How Trump’s second term will affect the medtech industry
From M&A and tariffs to new health leaders, here are the top issues for the medtech industry to watch during President Donald Trump’s return to office.
By Ricky Zipp • Dec. 10, 2024 -
Violeta Stoimenova via Getty Images
Haemonetics to offload whole-blood business for up to $67M
Selling the assets to Italy’s GVS should help Haemonetics improve its revenue growth and profit margins, analysts said.
By Susan Kelly • Dec. 4, 2024 -
Courtesy of GE Healthcare
GE Healthcare to buy radiopharmaceutical firm Nihon Medi-Physics
GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.
By Elise Reuter • Dec. 3, 2024 -
Courtesy of Intera Oncology
Boston Scientific to buy Intera Oncology, maker of liver cancer treatment
Intera makes a pump and a chemotherapy drug to treat liver tumors. Boston Scientific sees the purchase as a way to provide more comprehensive cancer treatments.
By Elise Reuter • Nov. 25, 2024 -
Courtesy of Medtronic
Medtronic buys surgical instrument developer Fortimedix
Fortimedix develops flexible surgical instruments that are responsive enough to navigate the body and enable endoscopic and minimally invasive procedures.
By Nick Paul Taylor • Nov. 22, 2024 -
Bruce Bennett via Getty Images
Henry Schein to acquire medical supplier Acentus
Acentus, which specializes in supplying glucose sensors to patients’ homes, continues Henry Schein’s recent focus on building its homecare medical supplies business.
By Ricky Zipp • Nov. 21, 2024 -
Courtesy of Boston Scientific
Boston Scientific closes $3.7B Axonics deal after lengthy review
Boston Scientific announced the acquisition in January, but the review dragged on after the Federal Trade Commission requested more information.
By Ricky Zipp • Nov. 15, 2024 -
Courtesy of Ambry Genetics
Tempus AI to buy genetic testing company for $600M
CEO Eric Lefkofsky said the purchase of Ambry Genetics will expand Tempus’ testing portfolio and bring in a fast-growing business.
By Elise Reuter • Nov. 6, 2024 -
Courtesy of Boston Scientific
Boston Scientific continues M&A run with Cortex buy
Cortex adds to Boston Scientific’s electrophysiology portfolio amid treatment shifts in the space driven by new pulsed field ablation devices.
By Ricky Zipp • Nov. 4, 2024 -
Courtesy of Boston Scientific
Boston Scientific to close Silk Road Medical headquarters, lay off 138 people
Following its acquisition of Silk Road in September, Boston Scientific said it plans to consolidate the company’s work in Minnesota.
By Elise Reuter • Oct. 28, 2024 -
Elise Reuter/MedTech Dive
The Medtech ConferenceThat’s a wrap: 5 takeaways from The Medtech Conference
The conference — Advamed’s largest — featured an appearance by the device center’s new acting director and sessions on AI, clinical trial diversity and the FDA’s contentious LDT rule.
By Elise Reuter • Oct. 22, 2024 -
FatCamera via Getty Images
Hologic to buy Gynesonics for $350M to acquire fibroid system
Gynesonics’ transcervical system uses ultrasound guidance and radiofrequency energy to ablate fibroids without the need for an incision.
By Nick Paul Taylor • Oct. 15, 2024 -
Janiecbros via Getty Images
Sponsored by Nemphos Braue5 reasons why MedTech M&A is poised for growth
In spite of uncertainties, the outlook for MedTech M&A is strong. Hint: AI isn’t the (only) factor.
By Caroline Popper, Nemphos Braue LLC • Oct. 7, 2024 -
Getty Images/Staff via Getty Images
Integer sells non-medical business for $50M
After making nearly $550 million worth of acquisitions in the past few years, the medical device contract manufacturer will use proceeds from the sale to pay down debt.
By Susan Kelly • Oct. 2, 2024 -
Mario Tama / Staff via Getty Images
What’s next at Masimo after CEO Kiani’s exit?
Investors are waiting to learn the next steps for the patient monitoring company after a hard-fought proxy battle, including how a separation of its consumer business could play out.
By Susan Kelly • Sept. 30, 2024 -
Getty Images via Getty Images
Stryker adds devices to remove brain tumors, clots with Nico buy
Nico sells devices for navigating through the brain, visualizing the organ, removing tumors and clots and collecting tissue.
By Nick Paul Taylor • Sept. 23, 2024 -
Courtesy of BusinessWire/Masimo
Masimo proxy fight nears end as shareholder vote looms
Chairman and CEO Joe Kiani’s board seat is on the line at today's shareholder meeting.
By Susan Kelly • Sept. 19, 2024 -
Courtesy of Cook Medical
Merit Medical inks $210M takeover of Cook’s lead management business
Merit predicts the portfolio, which includes devices used in procedures to remove or replace heart rhythm device leads, will add $40 million a year to its sales.
By Nick Paul Taylor • Sept. 18, 2024 -
Scott Olson via Getty Images
Bausch + Lomb considers sale: FT
Private equity could be “the most likely” buyer of the eye care business, analysts wrote.
By Elise Reuter • Sept. 16, 2024 -
Courtesy of Boston Scientific
Boston Scientific closes Silk Road Medical acquisition
Completion of the purchase comes three months after the companies announced the deal, and after Boston Scientific resubmitted its merger filing to give the FTC more review time.
By Ricky Zipp • Updated Sept. 17, 2024 -
Courtesy of Insightec
Medtech venture investment recovery continues, but startup M&A remains limited: Pitchbook
Acquisitions of late-stage VC startups have been rare, a fact Pitchbook attributed to “ongoing price gaps between buyers and sellers.”
By Nick Paul Taylor • Sept. 4, 2024 -
Courtesy of Grail
Illumina avoids fine for Grail purchase in European court victory
Illumina will avoid a penalty of 432 million euros after a court ruled the European Commission did not have jurisdiction to challenge the company’s Grail acquisition.
By Susan Kelly • Sept. 3, 2024
Previous
